Does the product plug a gap in my pipeline, secure my position in the market or enable me to access or establish myself in a specific territory?
Does the asset satisfy a high unmet need?
What level of market exclusivity does it realise, e.g. Global or local patent protection, Orphan Drug Designation, Biologic, New Chemical Entity
Is there a differentiated efficacy over the current standard of care (SOC)?
Do we have a complementary expertise which can be utilised to expedite a development product in both time to market and probability of success?
Can we leverage synergies through existing infrastructure e.g. R&D, supply chain, commercialisation capabilities etc?
Is there a strong management team at the licensor?
Can we get a high risk adjusted Internal Rate of Return (rIRR) percentage based on risk adjusted Net Present Value (rNPV) analysis?